Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men
Bradley D. Anawalt(University of Washington), Christina Wang(University of California, Los Angeles), Diana Blithe(National Institutes of Health), Mara Y. Roth(University of Washington), Régine Sitruk‐Ware(Population Council), Jonas Čeponis(Lithuanian University of Health Sciences), Clint Dart(Health Decisions (United States)), P. Y. Liu(The Lundquist Institute), Ronald S. Swerdloff(University of California, Los Angeles), Stephanie T. Page(University of Washington), William J. Bremner(University of Washington Medical Center), John K. Amory(University of Washington), N. Kumar(Population Council), Vijaya Surampudi(The Lundquist Institute)
Cited by 54
Related Papers
World Health Organization reference values for human semen characteristics*‡
|Human Reproduction Update|2009|2.8k
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2002|1.8k
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|1.6k
Advances in Male Contraception
|Endocrine Reviews|2008|1.1k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864